Excalibur Fund Manager
Excalibur Fund Managers is a specialised venture investor in life sciences companies managing and advising three funds, Merlin Fund (Fund I), Merlin Biosciences Fund (Fund II) and Merlin Biosciences Fund III (Fund III), worth in excess of €450 million of equity capital.
Excalibur invests in companies that are bringing to market human medicines or medical devices with groundbreaking technology and significant commercial potential. Since 1997, Excalibur has participated in the funding of 34 European biotechnology and life science companies on behalf of its investment partnerships.
Leveraging a worldwide, dedicated network of advisers and experienced strategic partners, Excalibur has built a reputation for being an exceptional partner for management teams who can create substantial value for investors.
Excalibur invests in companies that are bringing to market human medicines or medical devices with groundbreaking technology and significant commercial potential. Since 1997, Excalibur has participated in the funding of 34 European biotechnology and life science companies on behalf of its investment partnerships.
Leveraging a worldwide, dedicated network of advisers and experienced strategic partners, Excalibur has built a reputation for being an exceptional partner for management teams who can create substantial value for investors.
17th March 2009
Lab21 Limited raises a further £1.3m
Read this article
3rd March 2009
Lab21 Limited Acquires Biotec Laboratories SA
Read this article
5th February 2009
Destination Skin Limited voted best employer 2008
Read this article
